Scienture Holdings, Inc Financials
This page shows Scienture Holdings, Inc (SCNX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Scienture Holdings, Inc has an operating margin of -10758.7%, meaning the company retains $-10759 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -322.4% the prior year.
Scienture Holdings, Inc's revenue declined 90% year-over-year, from $1.4M to $137K. This contraction results in a growth score of 0/100.
Scienture Holdings, Inc carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Scienture Holdings, Inc's current ratio of 0.80 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 12/100, which could limit financial flexibility.
While Scienture Holdings, Inc generated -$14.3M in operating cash flow, capex of $12K consumed most of it, leaving -$14.3M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Scienture Holdings, Inc's ROE of 11.5% shows moderate profitability relative to equity, earning a score of 46/100.
Scienture Holdings, Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Scienture Holdings, Inc generates $-1.57 in operating cash flow (-$14.3M OCF vs $9.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Scienture Holdings, Inc earns $-11.0 in operating income for every $1 of interest expense (-$14.7M vs $1.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Scienture Holdings, Inc generated $137K in revenue in fiscal year 2024. This represents a decrease of 90.0% from the prior year.
Scienture Holdings, Inc's EBITDA was -$14.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 312.6% from the prior year.
Scienture Holdings, Inc generated -$14.3M in free cash flow in fiscal year 2024, representing cash available after capex.
Scienture Holdings, Inc reported $9.1M in net income in fiscal year 2024. This represents an increase of 150.8% from the prior year.
Scienture Holdings, Inc earned $2.48 per diluted share (EPS) in fiscal year 2024. This represents an increase of 110.6% from the prior year.
Scienture Holdings, Inc held $308K in cash against $2.9M in long-term debt as of fiscal year 2024.
Scienture Holdings, Inc had 9M shares outstanding in fiscal year 2024. This represents an increase of 626.2% from the prior year.
Scienture Holdings, Inc's gross margin was 4.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the prior year.
Scienture Holdings, Inc's operating margin was -10758.7% in fiscal year 2024, reflecting core business profitability. This is down 10436.3 percentage points from the prior year.
Scienture Holdings, Inc's net profit margin was 6634.7% in fiscal year 2024, showing the share of revenue converted to profit. This is up 7943.0 percentage points from the prior year.
Scienture Holdings, Inc's ROE was 11.5% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.
Scienture Holdings, Inc invested $2.2M in research and development in fiscal year 2024.
Scienture Holdings, Inc invested $12K in capex in fiscal year 2024, funding long-term assets and infrastructure.
SCNX Income Statement
| Metric | Q3'25 | Q3'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $590K+105.1% | $288K+2704.8% | $10K-99.4% | $1.7M+2514.7% | $65K+246.9% | $19K-98.8% | $1.5M+1254.1% | $112K |
| Cost of Revenue | $15K-69.9% | $51K+434.0% | $10K-97.8% | $446K+630.8% | $61K+214.3% | $19K-94.7% | $366K+50.8% | $243K |
| Gross Profit | $575K+142.9% | $237K+35045.8% | $673-99.9% | $1.3M+32099.3% | $4K+652.3% | -$703-100.1% | $1.1M+975.9% | -$131K |
| R&D Expenses | $169K-79.9% | $844K+46.8% | $575K | N/A | $1.3M | N/A | N/A | N/A |
| SG&A Expenses | $2.2M-26.0% | $2.9M+115.9% | $1.4M+9.5% | $1.2M+634.6% | $169K-59.4% | $415K-91.2% | $4.7M+451.8% | $852K |
| Operating Income | -$4.4M+15.4% | -$5.2M-44.4% | -$3.6M-900.1% | -$357K+89.8% | -$3.5M-133.9% | -$1.5M+72.8% | -$5.5M-146.4% | -$2.2M |
| Interest Expense | $1.8M+176.0% | $653K-2.6% | $671K+10364.6% | $6K-97.1% | $217K+4293.5% | $5K-95.0% | $99K-86.0% | $703K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$3.6M+46.3% | -$6.7M-119.3% | -$3.1M-518.7% | -$495K+84.4% | -$3.2M-73.6% | -$1.8M-108.6% | $21.2M+282.1% | -$11.7M |
| EPS (Diluted) | $-0.19+60.4% | $-0.48-45.5% | $-0.33-312.5% | $-0.08+94.0% | $-1.34-3.1% | $-1.30-107.8% | $16.77+212.8% | $-14.87 |
SCNX Balance Sheet
| Metric | Q3'25 | Q3'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $104.8M+0.5% | $104.3M-1.9% | $106.4M+1.4% | $104.9M+11.2% | $94.3M+534.8% | $14.8M-85.8% | $104.9M+736.6% | $12.5M |
| Current Assets | $1.4M+65.9% | $857K-89.1% | $7.8M+24.1% | $6.3M-13.1% | $7.3M-40.3% | $12.1M-13.4% | $14.0M+409.5% | $2.8M |
| Cash & Equivalents | $356K+2211.0% | $15K-99.2% | $2.0M+565.3% | $308K-46.8% | $579K-92.5% | $7.7M+120.6% | $3.5M+969100.0% | $361 |
| Inventory | $235K+1313.2% | $17K | N/A | $57K+620.0% | $8K+22.4% | $6K+19.9% | $5K+455.0% | $968 |
| Accounts Receivable | $590K+291.7% | $151K+3934.3% | $4K-66.4% | $11K+6.5% | $10K-20.3% | $13K+88.7% | $7K-18.3% | $8K |
| Goodwill | $21.4M0.0% | $21.4M0.0% | $21.4M0.0% | $21.4M+172.3% | $7.8M+981.1% | $726K0.0% | $726K | N/A |
| Total Liabilities | $22.2M-16.2% | $26.4M+4.9% | $25.2M-2.3% | $25.8M+182.5% | $9.1M+198.0% | $3.1M-96.6% | $91.2M+660.9% | $12.0M |
| Current Liabilities | $7.4M-4.4% | $7.7M+3.0% | $7.5M-5.6% | $7.9M+46.1% | $5.4M+86.5% | $2.9M-1.7% | $3.0M-74.5% | $11.6M |
| Long-Term Debt | $2.0M-44.1% | $3.6M+15.7% | $3.1M+6.7% | $2.9M | N/A | N/A | N/A | $667K |
| Total Equity | $82.7M+6.2% | $77.9M-4.1% | $81.2M+2.6% | $79.1M-7.1% | $85.1M+622.3% | $11.8M-13.5% | $13.6M+2411.1% | $542K |
| Retained Earnings | -$52.4M-7.4% | -$48.8M-16.0% | -$42.1M-7.8% | -$39.0M-22.5% | -$31.9M-20.3% | -$26.5M-7.4% | -$24.7M+25.8% | -$33.2M |
SCNX Cash Flow Statement
| Metric | Q3'25 | Q3'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.2M-58.0% | -$2.0M+31.2% | -$3.0M-1.6% | -$2.9M+46.0% | -$5.4M-227.6% | $4.2M+141.4% | -$10.2M-899.9% | -$1.0M |
| Capital Expenditures | $0 | N/A | N/A | $0-100.0% | $3K | N/A | N/A | N/A |
| Free Cash Flow | -$287K | N/A | N/A | -$2.9M-1078.6% | -$247K | N/A | N/A | N/A |
| Investing Cash Flow | $0 | N/A | N/A | $0-100.0% | $121K+15730.0% | -$774-100.0% | $27.4M+7937.9% | -$350K |
| Financing Cash Flow | $3.6M | $0-100.0% | $4.7M+68.4% | $2.8M+248.9% | -$1.9M | $0+100.0% | -$13.9M-1140.6% | $1.3M |
| Dividends Paid | N/A | N/A | N/A | $0-100.0% | $2.2M | $0-100.0% | $12.7M | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SCNX Financial Ratios
| Metric | Q3'25 | Q3'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 97.4%+15.2pp | 82.2%+75.7pp | 6.6%-67.2pp | 73.7%+67.7pp | 6.0%+9.8pp | -3.8%-79.6pp | 75.8%+193.0pp | -117.2% |
| Operating Margin | -739.1%-634.8pp | -104.3%+34710.7pp | -34814.9%-34793.9pp | -21.1%+5371.7pp | -5392.8%+2606.0pp | -7998.8%-8010.1pp | 11.4%+2006.8pp | -1995.4% |
| Net Margin | -611.4%-506.8pp | -104.6%+29764.7pp | -29869.3%-29840.1pp | -29.2%+4879.1pp | -4908.3%+4899.2pp | -9807.5%-9815.8pp | 8.3%+10451.8pp | -10443.5% |
| Return on Equity | N/A | N/A | N/A | N/A | 0.7%-3.6pp | 4.3%-151.7pp | 156.0% | N/A |
| Return on Assets | -3.4%+3.0pp | -6.4%-3.6pp | -2.9%+6.0pp | -8.9%-5.5pp | -3.4%+9.0pp | -12.3%-32.6pp | 20.3%+113.3pp | -93.1% |
| Current Ratio | 0.19+0.1 | 0.11-0.9 | 1.05+0.3 | 0.80-0.5 | 1.34-2.8 | 4.18-0.6 | 4.75+4.5 | 0.24 |
| Debt-to-Equity | 0.02-0.0 | 0.050.0 | 0.040.0 | 0.04-0.1 | 0.11-0.2 | 0.26-6.4 | 6.70-15.4 | 22.11 |
| FCF Margin | -77.0% | N/A | N/A | N/A | -76.3% | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.80), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Scienture Holdings, Inc's annual revenue?
Scienture Holdings, Inc (SCNX) reported $137K in total revenue for fiscal year 2024. This represents a -90.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scienture Holdings, Inc's revenue growing?
Scienture Holdings, Inc (SCNX) revenue declined by 90% year-over-year, from $1.4M to $137K in fiscal year 2024.
Is Scienture Holdings, Inc profitable?
Yes, Scienture Holdings, Inc (SCNX) reported a net income of $9.1M in fiscal year 2024, with a net profit margin of 6634.7%.
What is Scienture Holdings, Inc's earnings per share (EPS)?
Scienture Holdings, Inc (SCNX) reported diluted earnings per share of $2.48 for fiscal year 2024. This represents a 110.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Scienture Holdings, Inc's EBITDA?
Scienture Holdings, Inc (SCNX) had EBITDA of -$14.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Scienture Holdings, Inc have?
As of fiscal year 2024, Scienture Holdings, Inc (SCNX) had $308K in cash and equivalents against $2.9M in long-term debt.
What is Scienture Holdings, Inc's gross margin?
Scienture Holdings, Inc (SCNX) had a gross margin of 4.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scienture Holdings, Inc's operating margin?
Scienture Holdings, Inc (SCNX) had an operating margin of -10758.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Scienture Holdings, Inc's net profit margin?
Scienture Holdings, Inc (SCNX) had a net profit margin of 6634.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Scienture Holdings, Inc's return on equity (ROE)?
Scienture Holdings, Inc (SCNX) has a return on equity of 11.5% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Scienture Holdings, Inc's free cash flow?
Scienture Holdings, Inc (SCNX) generated -$14.3M in free cash flow during fiscal year 2024. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scienture Holdings, Inc's operating cash flow?
Scienture Holdings, Inc (SCNX) generated -$14.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Scienture Holdings, Inc's total assets?
Scienture Holdings, Inc (SCNX) had $104.9M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Scienture Holdings, Inc's capital expenditures?
Scienture Holdings, Inc (SCNX) invested $12K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Scienture Holdings, Inc spend on research and development?
Scienture Holdings, Inc (SCNX) invested $2.2M in research and development during fiscal year 2024.
How many shares does Scienture Holdings, Inc have outstanding?
Scienture Holdings, Inc (SCNX) had 9M shares outstanding as of fiscal year 2024.
What is Scienture Holdings, Inc's current ratio?
Scienture Holdings, Inc (SCNX) had a current ratio of 0.80 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Scienture Holdings, Inc's debt-to-equity ratio?
Scienture Holdings, Inc (SCNX) had a debt-to-equity ratio of 0.04 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scienture Holdings, Inc's return on assets (ROA)?
Scienture Holdings, Inc (SCNX) had a return on assets of 8.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Scienture Holdings, Inc's cash runway?
Based on fiscal year 2024 data, Scienture Holdings, Inc (SCNX) had $308K in cash against an annual operating cash burn of $14.3M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Scienture Holdings, Inc's Piotroski F-Score?
Scienture Holdings, Inc (SCNX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scienture Holdings, Inc's earnings high quality?
Scienture Holdings, Inc (SCNX) has an earnings quality ratio of -1.57x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Scienture Holdings, Inc cover its interest payments?
Scienture Holdings, Inc (SCNX) has an interest coverage ratio of -11.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Scienture Holdings, Inc?
Scienture Holdings, Inc (SCNX) scores 26 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.